Endothelial cell activation by antiphospholipid antibodies

Clinical Immunology : the Official Journal of the Clinical Immunology Society
P L MeroniM O Borghi

Abstract

Antiphospholipid antibodies are mainly directed against beta 2 glycoprotein I, a phospholipid-binding protein expressed on endothelial cell membranes of different anatomical localizations and recognized by the specific autoantibodies. Antibody binding induces an endothelial activation both in in vitro and in vivo experimental models that might contribute to the prothrombotic state. Endothelial beta 2 glycoprotein I adhesion is mediated by the electrostatic interaction between its cationic phospholipid binding site and anionic structures on the cell membrane; however, binding to annexin II--the endothelial cell receptor for tissue plasminogen activator--plays also a role. Anti-beta-2 glycoprotein I antibodies up-regulate mRNA expression of pro-inflammatory mediators through NF-kappaB translocation and the signaling cascade triggered by Toll-like receptors. Because of the molecular mimicry between beta 2 glycoprotein I and viral/bacterial structures-the natural ligands for Toll-like receptors (TLR)-antibodies might cross-link the molecule associated to the receptors eventually triggering their signaling.

References

Oct 1, 1992·American Journal of Reproductive Immunology : AJRI·J A McIntyre
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J E HuntS A Krilis
Nov 14, 1998·Lupus·R A Roubey
Apr 21, 1999·Current Opinion in Cell Biology·F Mercurio, A M Manning
May 20, 1999·The New England Journal of Medicine·R D Rosenberg, W C Aird
Jun 22, 1999·The New England Journal of Medicine·G D Sloop
Sep 2, 2000·Journal of Autoimmunity·S S PierangeliE N Harris
Sep 6, 2001·Rheumatic Diseases Clinics of North America·P L MeroniG Balestrieri
Sep 6, 2001·Rheumatic Diseases Clinics of North America·J GeorgeY Shoenfeld
Oct 18, 2001·Current Opinion in Rheumatology·P L Meroni, P Riboldi
Mar 22, 2002·Nature Reviews. Immunology·R Medzhitov
Jul 12, 2002·The New England Journal of Medicine·Phillip Periman
Jan 13, 2004·Lupus·P L MeroniA Salmaggi
Mar 5, 2004·Journal of Clinical Immunology·M BlankY Shoenfeld
May 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hong QiuJesper Z Haeggström

❮ Previous
Next ❯

Citations

Feb 15, 2012·Nature Reviews. Rheumatology·Brian J SkaggsMaureen McMahon
Dec 14, 2005·Annals of the Rheumatic Diseases·Y ShoenfeldP-L Meroni
Jan 31, 2007·Annals of the Rheumatic Diseases·Silvia S PierangeliPier Luigi Meroni
Feb 24, 2006·Blood·Gabriela Cesarman-MausKatherine A Hajjar
Jul 20, 2012·Case Reports in Medicine·Nobuhiro SuzumoriMayumi Sugiura-Ogasawara
Dec 24, 2013·Antioxidants & Redox Signaling·Elena OrtonaMarina Pierdominici
Sep 24, 2013·Thrombosis Research·Karim J BrandtPhilippe de Moerloose
Apr 12, 2007·Clinical Reviews in Allergy & Immunology·Pier Luigi MeroniMaria Orietta Borghi
Mar 30, 2006·Current Rheumatology Reports·Joan T Merrill
Apr 29, 2010·Current Rheumatology Reports·Julia HurstPhilipp von Landenberg
Jun 1, 2005·Rheumatic Diseases Clinics of North America·Andrea DoriaYehuda Shoenfeld
Jul 15, 2005·Annals of the New York Academy of Sciences·Wolfgang MiesbachInge Scharrer
Aug 30, 2005·Annals of the New York Academy of Sciences·Karina de LeeuwMarc Bijl
Jul 17, 2007·American Journal of Reproductive Immunology : AJRI·Silvia D'IppolitoAlessandro Caruso
Jul 21, 2006·Annals of the New York Academy of Sciences·Nicoletta di SimoneAlessandro Caruso
May 2, 2007·Journal of Thrombosis and Haemostasis : JTH·M T T PenningsP G de Groot
Sep 26, 2007·Annals of the New York Academy of Sciences·Nicoletta Di SimoneCaruso Alessandro
Nov 24, 2007·Journal of Thrombosis and Haemostasis : JTH·P L MeroniA Tincani
Nov 22, 2005·Clinical and Experimental Immunology·S OwensP M Johnson
Oct 12, 2007·Tissue Antigens·I SantinJ R Bilbao
Jan 15, 2005·Biochemical and Biophysical Research Communications·Susanne KirschnekErich Gulbins
Mar 21, 2006·Neuroscience Research·Tetsuo Yamamori, Kathleen S Rockland
Apr 2, 2016·Current Rheumatology Reports·Kimberly Janet LegaultGuillermo Ruiz-Irastorza
Jan 15, 2014·La Revue de médecine interne·Y BenhamouR Joannidès
Sep 10, 2014·La Presse médicale·Zoubida Tazi MezalekPatrice Cacoub
Feb 3, 2005·International Immunopharmacology·Enrico Maria ZardiAntonella Afeltra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.